Literature DB >> 3114803

Promethazine, scopolamine and cinnarizine: comparative time course of psychological performance effects.

A C Parrott, K Wesnes.   

Abstract

Single oral doses of promethazine (12.5 mg, 25 mg), scopolamine (0.6 mg), and cinnarizine (30 mg), were compared in a double-blind, placebo controlled trial. Twelve normal volunteers undertook a battery of psychological performance tests and a feeling state questionnaire, before drug administration, and at 2-h intervals after. Promethazine and cinnarizine significantly impaired psychomotor performance, information processing and feelings of alertness. With promethazine these reductions were maximal 3-4 h post-drug, with performance returning near to baseline 8-9 h post-drug. With cinnarizine these impairments were maximal 5-6 h post-drug, and performance remained depressed 8-9 h post-drug. Scopolamine significantly reduced feelings of alertness, and memory task performance; the overall performance effects were most evident 1-4 h post-drug.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3114803     DOI: 10.1007/bf00176487

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  32 in total

1.  Relative efficacy of the proposed Space Shuttle antimotion sickness medications.

Authors:  J R Hordinsky; E Schwartz; J Beier; J Martin; G Aust
Journal:  Acta Astronaut       Date:  1982 Jun-Jul       Impact factor: 2.413

2.  Effect of certain drugs on the incidence of seasickness.

Authors:  R TRUMBULL; H I CHINN; C H MAAG; L J MILCH; S W HANDFORD; R SEIBERT; P SPERLING; P K SMITH
Journal:  Clin Pharmacol Ther       Date:  1960 May-Jun       Impact factor: 6.875

3.  The effects of transdermal scopolamine and four dose levels of oral scopolamine (0.15, 0.3, 0.6, and 1.2 mg) upon psychological performance.

Authors:  A C Parrott
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Antimotion sickness and antiemetic drugs.

Authors:  C D Wood
Journal:  Drugs       Date:  1979-06       Impact factor: 9.546

5.  Interactions, range effects, and comparisons between tasks in experiments measuring performance with pairs of stresses: mild heat and 1 mg of L-hyoscine hydrobromide.

Authors:  E C Poulton; R S Edwards
Journal:  Aerosp Med       Date:  1974-07

Review 6.  The Stroop color-word test: a review.

Authors:  A R Jensen; W D Rohwer
Journal:  Acta Psychol (Amst)       Date:  1966

7.  Central effects of H1 and H2 antihistamines.

Authors:  A N Nicholson
Journal:  Aviat Space Environ Med       Date:  1985-04

8.  Drugs as research tools in psychology: cholinergic drugs and information processing.

Authors:  D M Warburton; K Wesnes
Journal:  Neuropsychobiology       Date:  1984       Impact factor: 2.328

9.  The separate and combined effects of scopolamine and nicotine on human information processing.

Authors:  K Wesnes; A Revell
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Effects of scopolamine on stimulus sensitivity and response bias in a visual vigilance task.

Authors:  K Wesnes; D M Warburton
Journal:  Neuropsychobiology       Date:  1983       Impact factor: 2.328

View more
  6 in total

1.  RU 41,656 does not reverse the scopolamine-induced cognitive deficit in healthy volunteers.

Authors:  A Patat; M J Klein; A Surjus; M Hucher; J Granier
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  The effects of the selective muscarinic M3 receptor antagonist darifenacin, and of hyoscine (scopolamine), on motion sickness, skin conductance & cognitive function.

Authors:  John F Golding; Keith A Wesnes; Brian R Leaker
Journal:  Br J Clin Pharmacol       Date:  2018-04-19       Impact factor: 4.335

3.  The value of assessing cognitive function in drug development.

Authors:  K A Wesnes
Journal:  Dialogues Clin Neurosci       Date:  2000-09       Impact factor: 5.986

Review 4.  Migraine Pharmacological Treatment and Cognitive Impairment: Risks and Benefits.

Authors:  Mirella Russo; Matteo A De Rosa; Dario Calisi; Stefano Consoli; Giacomo Evangelista; Fedele Dono; Matteo Santilli; Alberto Granzotto; Marco Onofrj; Stefano L Sensi
Journal:  Int J Mol Sci       Date:  2022-09-27       Impact factor: 6.208

5.  A computerized stroop test for the evaluation of psychotropic drugs in healthy participants.

Authors:  Raveendranadh Pilli; Mur Naidu; Usha Rani Pingali; J C Shobha; A Praveen Reddy
Journal:  Indian J Psychol Med       Date:  2013-04

6.  Amelioration of the haloperidol-induced memory impairment and brain oxidative stress by cinnarizine.

Authors:  Omar M E Abdel-Salam; Marwa El-Sayed El-Shamarka; Neveen A Salem; Aliaa E M K El-Mosallamy; Amany A Sleem
Journal:  EXCLI J       Date:  2012-08-27       Impact factor: 4.068

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.